Takeda Pharmaceutical (TAK) Gets Priority Review. Can Zasocitinib Win in Psoriasis?
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Health & Medicine
Fighting in Yemen pushing health system to ‘collapse’, says WHO chief
Fighting in Yemen pushing health system to ‘collapse’, says WHO chief Escalating tensions in Yemen are “pushing an already fragile health system closer to collapse”, director general of the World…
Where Does Medicine's Responsibility for Human Trafficking End?
(MedPage Today) -- In a recent New England Journal of Medicine Perspective, Nicholas Peoples, MD, of Massachusetts General Hospital in Boston, and colleagues argued that physicians have a role not…
Walmart launches rural health ambassador pilot, tapping pharmacists for expanded support
Walmart’s Health Ambassador Associate roles will be given to trained pharmacists at each store participating in the program.
MoH probes expat doctor over patient privacy violations, photo publication
RIYADH — The Ministry of Health launched probe into the patient privacy violations committed by an expatriate pediatrician.
New findings shed light on rare newly identified TCF7L2-related neurodevelopmental disorder
Researchers have completed the largest study to date of TCF7L2-related neurodevelopmental disorder (TRND), a rare genetic condition caused by changes in the TCF7L2 gene, which plays an important role…
First Drug Approved for Type 1 Diabetes-Associated Kidney Disease in Decades
(MedPage Today) -- The FDA approved finerenone (Kerendia) for adults with type 1 diabetes-associated chronic kidney disease (CKD), marking the first new treatment option for this population in more…